中联品牌怎么样 申请店铺

我要投票 中联在医疗器械行业中的票数:204 更新时间:2025-05-17
中联是哪个国家的品牌?「中联」是 国药集团中联药业有限公司 旗下著名品牌。该品牌发源于湖北省武汉市,由创始人蒋焘在1998-04-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中联品牌出海!将品牌入驻外推网,定制中联品牌推广信息,可以显著提高中联产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

中联怎么样

国药中联有着悠久的历史,由拥有四百余年中医药历史并享誉全国的叶开泰、达仁堂、刘有余堂金同仁、九芝堂、陈太乙等为代表的192家中药店铺联合组建而成。1952年,在原武汉市中药饮片业同业公会的发动下,成立武汉市中联制药厂。1997年股份制改造,2002年成立集团公司,2011年底重组进入中国较大的健康产业平台――中国医药集团。经过60余年发展壮大,公司已形成包括中成药、化学制剂生产和销售、医药商业营运等在内的多种产业结构,成为集科研、生产、流通、外贸于一体的专业医药健康企业。

公司专注经典中药生产与销售。拥有注册产品300余个,有82个品种列入国家基本药物目录,有14个品种,其中战略大品种鳖甲煎丸有两千多年历史,为汉代张仲景经典古方,专治胁下癥块。公司产品涉足肝脏用药、呼吸系统用药、妇科用药、心脑血管用药等特色领域,已形成以鳖甲煎丸为代表的肝脏用药系列,以金叶败毒颗粒、鼻炎片、强力感冒片为代表的呼吸道用药系列,以脉君安片、心脑清软胶囊为代表的心脑血管用药系列,以加味生化颗粒为代表的妇科用药系列。

公司注重经典中药的系统深度开发。依托国药集团旗下中国医药工业研究总院研发平台,广泛开展国内、国际合作与交流,不断探索经典古方治病机理,研究新工艺,保障产品疗效,拥有多项自主知识产权,为公司的可持续发展奠定了坚实地基础。

公司营销网络遍布全国多省、自治区、直辖市,终端销售网点覆盖全国,主要品种出口日本、马来西亚、印尼、美国等国家和地区。公司不仅销售产品,同时专注于将中医药哲学(文化)、产品核心价值传递给医生和患者,使“中联”成为受医生和患者尊重的制药企业,为中国中医药的发展贡献力量。

公司在东湖高新技术开发区光谷生物城按照现代中药生产标准兴建的“中联中医药产业园”已经建成,未来,公司将以此为依托,以“挖掘传承创新发扬中国中药,为‘家人’提供经典好中药”为已任,传承发扬中国中药,力争成为国内优秀现代化中药企业。十三五末营业收入过十亿元,利润过亿元。


Sinopharm has a long history. It is composed of 192 traditional Chinese medicine stores represented by Ye Kaitai, Da Rentang, Liu youyutang, Jin Tongren, Jiuzhitang and Chen Taiyi, who have more than 400 years of traditional Chinese medicine history and are well-known throughout the country. In 1952, Wuhan Zhonglian pharmaceutical factory was established under the initiative of the former Wuhan herbal medicine industry association. In 1997, the joint-stock system was reformed, and the group company was established in 2002. At the end of 2011, it was reorganized into China's larger health industry platform, China Pharmaceutical Group. After more than 60 years of development and expansion, the company has formed a variety of industrial structures, including the production and sales of Chinese patent medicine, chemical preparations, pharmaceutical commercial operation, etc., and has become a professional pharmaceutical health enterprise integrating scientific research, production, circulation and foreign trade. The company focuses on the production and sales of classic Chinese medicine. There are more than 300 registered products, 82 varieties are listed in the national basic drug catalog, and 14 varieties, of which the strategic big variety Biejiajian Pill has a history of more than 2000 years. It is a classic ancient recipe of Zhang Zhongjing in Han Dynasty and specializes in treating hypochondriac diseases. The company's products are involved in the fields of liver medicine, respiratory system medicine, gynecology medicine, cardio cerebral vascular medicine, etc. it has formed a series of liver medicine represented by Biejiajian Pill, respiratory medicine represented by Jinyebaidu granule, Biyan tablet, qiangliganmao tablet, cardio cerebral vascular medicine represented by maijunan tablet and xinnaoqing soft capsule, and Jiawei biochemical granule The representative series of gynecological medicine. The company pays attention to the systematic and in-depth development of traditional Chinese medicine. Relying on the R & D platform of China Pharmaceutical Industry Research Institute under Sinopharm group, the company has extensively carried out domestic and international cooperation and exchanges, constantly explored the mechanism of classical ancient prescriptions, studied new technologies, guaranteed the product efficacy, and possessed a number of independent intellectual property rights, laying a solid foundation for the company's sustainable development. The company's marketing network covers many provinces, autonomous regions and municipalities directly under the central government, and the terminal sales outlets cover the whole country. The main products are exported to Japan, Malaysia, Indonesia, the United States and other countries and regions. The company not only sells products, but also focuses on delivering the Philosophy (Culture) and core values of traditional Chinese medicine to doctors and patients, making Zoomlion a pharmaceutical enterprise respected by doctors and patients and contributing to the development of traditional Chinese medicine in China. The "Zhonglian traditional Chinese medicine industrial park" built by the company in the Guanggu biological city of Donghu high tech Development Zone in accordance with the production standards of modern traditional Chinese medicine has been completed. In the future, the company will take this as the support, take "mining, inheriting, innovating and carrying forward Chinese traditional medicine, providing classic and good traditional Chinese medicine for" family "as the responsibility, inherit and carry forward Chinese traditional medicine, and strive to become an excellent modern Chinese medicine enterprise in China. At the end of the 13th five year plan, the operating revenue was over one billion yuan and the profit was over one billion yuan.

本文链接: https://brand.waitui.com/9f77d79a5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

香港新冠病毒活跃程度处于高水平 专家:或因病毒株出现变异

据香港电台网站5月17日消息,香港新冠病毒活跃程度处于高水平,儿童及成人严重个案的数字亦录得升幅。香港卫生防护中心辖下疫苗可预防疾病科学委员会主席刘宇隆认为,导致新一轮的新冠疫情爆发,原因很复杂,但估计主要可能因病毒株出现变异,污水监测显示更多是KP.3病毒株。

2小时前

中国科学院物理研究所与B站联合主办2025年公众科学日

36氪获悉,5月17日,中国科学院2025年公众科学日举办。此次活动由中国科学院物理研究所与B站联合主办。今年是中国科学院学部成立的第70周年,也是B站与中国科学院物理研究所合作的第7个年头,作为独家直播平台,B站全程直击院士讲座、UP主科学秀等六大核心活动,吸引超千万用户在线观看。数据显示,B站汇聚了648名高校教授及专家学者,70%的中国Z世代活跃于B站,在B站探索多元的知识内容与科技洞见。

2小时前

上海助推2万余款新品跑上“首发快车道”

据新华社,从此间举行的新闻通气会上了解到,作为“首发上海3.0”政策中的新措施之一,上海在全国率先试点的首发进口消费品检验便利化措施实施以来,已有14家跨国企业20个消费品品牌的两万多款首发新品跑上在中国首发的“快车道”。

2小时前

多个非洲国家看好中国出境游市场潜力 将推更多针对性措施吸引中国游客

2025非洲旅游大会5月13日至15日在南非海滨城市德班举行。多名与会非洲国家官员表示,看好中国出境游市场潜力,将推出更多针对性措施,吸引中国游客来非洲旅游。作为非洲规模最大的旅游展会之一,非洲旅游大会今年吸引了27个非洲国家的1300多家参展商和来自55个国家及地区的1200多家采购商参会。(财联社)

2小时前

算力互联网试验网建设正式启动

据新华社,17日,2025世界电信与信息社会日纪念活动暨国际电信联盟160周年活动在江西南昌举行。其间,中国电信、中国移动、中国联通联合中国信息通信研究院正式启动算力互联网试验网建设。中国信通院副院长王志勤介绍,算力互联网是落实国家关于加快形成全国一体化算力体系重点任务要求,推动我国算力产业提质增效、加快培育新质生产力的具体实践。建设运行算力互联网试验网,将持续优化全国算力资源布局,助力人工智能等领域科技创新,促进数字经济与实体经济深度融合,为我国高质量发展注入新动能。

2小时前

本页详细列出关于中联的品牌信息,含品牌所属公司介绍,中联所处行业的品牌地位及优势。
咨询